Amneal Pharmaceuticals AMRX
NASDAQ AMRX
$21.49 +0.11 (+0.51%)
As of: Nov 16, 2026 · 9:46 AM EST

Amneal Pharmaceuticals (AMRX) Research & Development (2017 - 2026)

Updated

Amneal Pharmaceuticals (AMRX) posted Research & Development of $68.37 million for Q3 2026, up 7.9% from $63.35 million a year earlier and up 75.2% from the prior quarter.

Analysis

Amneal Pharmaceuticals (AMRX) Research & Development (2017 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, Research & Development at Amneal Pharmaceuticals was $180.59 million, down 12.2% year-over-year; for FY2025, it came in at $186.18 million, down 2.4% from FY2024.

  • Annual Research & Development shows a five-year compound annual growth rate of 0.7% (FY2020 to FY2025).
  • In prior years, Amneal Pharmaceuticals' Research & Development was $190.71 million in FY2024 (+16.3%), $163.95 million in FY2023 (-16.2%), $195.69 million in FY2022 (-3.1%) and $201.85 million in FY2021 (+12.2%).
  • The Q3 2026 figure stands as the highest quarterly Research & Development in data going back to Q2 2017.
  • On a year-over-year basis, Research & Development increased in five of the last eight quarters, with growth averaging 0.7%.
  • The strongest year-over-year quarter for Research & Development in the past five years was Q3 2024, with growth of 47.7%; the weakest was Q4 2025, with a decline of 35.8%.
  • According to Business Quant data, Research & Development for the three prior quarters was $39.02 million (Q2 2026), $38.38 million (Q1 2026) and $34.82 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Eli Lilly 1,305.71 Bn 1,279.33 Bn 20.46 Bn 4.25 Bn
2 Johnson & Johnson 694.23 Bn 614.09 Bn 17.30 Bn 4.65 Bn
3 AbbVie 528.96 Bn 496.97 Bn 13.12 Bn 2.57 Bn
4 Merck 365.92 Bn 328.86 Bn 13.19 Bn 4.54 Bn
5 Novartis Ag 314.95 Bn 288.19 Bn - -
6 Astrazeneca 289.15 Bn 262.67 Bn 13.26 Bn 3.89 Bn
7 Amgen 254.11 Bn 205.76 Bn 7.58 Bn 2.11 Bn
8 Gilead Sciences 211.85 Bn 186.96 Bn 6.73 Bn 1.61 Bn
9 Pfizer 165.73 Bn 113.09 Bn 12.56 Bn 3.02 Bn
10 Amneal Pharmaceuticals 7.21 Bn 6.44 Bn 334.12 Mn 68.37 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 68.37 Mn
Jun 30, 2026 39.02 Mn
Mar 31, 2026 38.38 Mn
Dec 31, 2025 34.82 Mn
Sep 30, 2025 63.35 Mn
Jun 30, 2025 47.96 Mn
Mar 31, 2025 40.04 Mn
Dec 31, 2024 54.27 Mn
Sep 30, 2024 61.10 Mn
Jun 30, 2024 36.05 Mn
Mar 31, 2024 39.30 Mn
Dec 31, 2023 46.09 Mn
Sep 30, 2023 41.38 Mn
Jun 30, 2023 37.80 Mn
Mar 31, 2023 38.69 Mn
Dec 31, 2022 41.91 Mn
Sep 30, 2022 50.24 Mn
Jun 30, 2022 50.75 Mn
Mar 31, 2022 52.80 Mn
Dec 31, 2021 51.87 Mn
API Access

Amneal Pharmaceuticals Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=AMRX&period=max&api_key=YOUR_API_KEY